Abstract
To search for an economical and convenient synthesis of sunitinib and its malate salt, optimization of a scalable synthetic route was explored by designing a standard experimental protocol on laboratory scale using commercially available materials including acetyl ethyl acetate, 4-fluoroaniline, and N 1,N 1-diethylethane-1,2-diamine. The optimal conditions were established based on investigating the main reaction steps, including cyclization, hydrolysis, decarboxylation, formylation, and condensation, giving optimized yields for each step of 94.4, 97.6, 98.5, 97.1, 91.0, 86.3, 85.5, 88.2, 99.1, 97.3, and 58.7 %, respectively. The synthesis process of 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid as the important intermediate was significantly improved by using solvent-free decarboxylation instead of the traditional process in a high-boiling-point solvent. The subsequent formylation was conducted directly using the dichloromethane solution of the crude product from decarboxylation, leading to an almost quantitative combined yield of these two steps. The overall yields of sunitinib and its salt using the optimal synthesis process were 67.3 and 40.0 % based on acetyl ethyl acetate. The obtained data could be used as reference for future industrialization, especially for avoiding expensive solvents and reducing reaction time.
Similar content being viewed by others
References
F. Musumeci, M. Radi, C. Brullo, S. Schenone, J. Med. Chem. 55(24), 10797–10822 (2012)
R. Roskoski Jr, Biochem. Biophys. Res. Commun. 356(2), 323–328 (2007)
S. Schenone, C. Brullo, M. Botta, Curr. Med. Chem. 15(29), 3113–3132 (2008)
C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Adv. Drug Del. Rev. 46(1–3), 3–26 (2001)
J.M. Manley, M.J. Kalman, B.G. Conway, C.C. Ball, J.L. Havens, R. Vaidyanathan, J. Org. Chem. 68(16), 6447–6450 (2003)
L. Sun, C. Liang, S. Shirazian, Y. Zhou, T. Miller, J. Cui, J.Y. Fukuda, J.-Y. Chu, A. Nematalla, X. Wang, H. Chen, A. Sistla, T.C. Luu, F. Tang, J. Wei, C. Tang, J. Med. Chem. 46(7), 1116–1119 (2003)
J.Q. Wang, K.D. Miller, G.W. Sledge, Q.H. Zheng, Bioorg. Med. Chem. Lett. 15(19), 4380–4384 (2005)
K. Sidoryk, M. Malinska, K. Bankowski, M. Kubiszewski, M. Laszcz, M. Bodziachowska-Panfil, M. Kossykowska, T. Giller, A. Kutner, K. Wozniak, J. Pharm. Sci. 102(2), 706–716 (2013)
K. Lv, L.L. Wang, M.L. Liu, X.B. Zhou, S.Y. Fan, H.Y. Liu, Z.B. Zheng, S. Li, Bioorg. Med. Chem. Lett. 21(10), 3062–3065 (2011)
R. Vaidyanathan, V.G. Kalthod, D.P. Ngo, J.M. Manley, S.P. Lapekas, J. Org. Chem. 69(7), 2565–2568 (2004)
Z. Fang, P. Wei, Z. Yang, Chin. J. Pharm. 38(11), 822–824 (2007)
G. Meng, M.-L. Zheng, M. Wang, Org. Prep. Proced. Int. 43(3), 308–311 (2011)
B. Liu, R. Lin, J. Liao, Z. Li, K. Chen, Chin. J. Pharm. 38(8), 539–542 (2007)
Z. Fang, Z. Yang, S. Bao, W. Wang, P. Wei, Huaxue Shiji 32(1), 82–84 (2010)
V.Q. Yen, N.P. Buu-Hoi, N.D. Xuong, J. Org. Chem. 23(12), 1858–1861 (1958)
K. Lv, Y. Du, D. Zhao, Z. Zheng, S. Li, Chinese. J. Med. Chem. 19(2), 116–119 (2009)
R.A. Schnettler, R.C. Dage, J.M. Grisar, U.S. Patent 4560700, 24 Dec 1985
J.V. Cooney, E.J. Beal, R.N. Hazlett, Org. Prep. Proced. Int. 15(4), 292–295 (1983)
P. Tang, T.A. Miller, X. Li, L. Sun, C.C. Wei, S. Shirazian, C. Liang, T. Vojkovsky, A.S. Nematala, M. Hawley, ed. WO (US, 2002)
K.C. Joshi, V.N. Pathak, S.K. Jain, Pharmazie 35(11), 677–679 (1980)
X. Dong, F. Zhou, R. Wen, Chinese. J. Med. Chem. 18(1), 28–31 (2008)
Acknowledgments
The authors would like to thank the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM), P.R. China (JWSL 20101561) and Technology Research and Development Program of China, International Cooperation (2013KW31-04) for financial support. The research work has also been sponsored by the National Undergraduate Innovative Experiment Program (2012).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Meng, G., Liu, C., Qin, S. et al. An improved synthesis of sunitinib malate via a solvent-free decarboxylation process. Res Chem Intermed 41, 8941–8954 (2015). https://doi.org/10.1007/s11164-015-1939-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-015-1939-z